RWRay Y. Wang

Ray Y. Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ray Y. Wang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical Characteristics and Survival in Adenoid Cystic Carcinoma of Salivary and Nonsalivary Sites

    by Ray Y. Wang, Kristina R. Dahlstrom, Erich M. Sturgis

    Objectives: Adenoid cystic carcinoma (ACC) typically arises from salivary glands of the head and neck but also occurs in sites outside of the head and neck; however, data regarding nonsalivary ACC are scarce. We present a comparison of the clinical behavior, treatment patterns, and survival outcomes of ACC of salivary and nonsalivary sites using the National Cancer Database (NCDB). Methods: Retrospective analysis of patients diagnosed with ACC between 2004 and 2020 in NCDB. Patients were identified using the histology code 8200 and categorized by site based on primary site ICD‐O‐3 codes. Anatomic sites with more than 100 patients were included for analysis. Results: A total of 16,962 patients with ACC from seven sites (major salivary, minor salivary, respiratory, skin, breast, female genital, and eye/orbit) were included in the final analysis. Among all sites, minor salivary gland tumors were most likely to present with locally advanced disease (T3 or T4) while those of the respiratory tract were most likely to present with regional (26%) or distant metastasis (11.1%). On multivariate analysis controlling for age, sex, treatment, T and N classification, only breast primaries had significantly different survival from major salivary primaries (HR 0.59, 95% CI 0.49–0.72). Conclusion: The clinical behavior of ACC varies significantly by anatomic primary site. Survival differences between the different anatomic sites appear to be driven largely by differences in the extent of disease at presentation, although patients with breast primaries had significantly better survival than salivary gland primaries even when controlling for these factors. Level of Evidence: 3.

  • Clinical behavior and predictors of survival in major salivary gland secretory carcinoma

    by Ray Y Wang, Angela L Mazul, Randall C Paniello, Jason T Rich, Paul Zolkind, Ryan S Jackson, Patrik Pipkorn, Sidharth V Puram

  • Open Access

    Transoral Robotic‐Assisted Removal of a Submucosal Pyriform Sinus Foreign Body

    by Elisabeth Wenneker, Rebecca Doctor, Ari Schuman, Adam Szymanowski, Ray Wang

    Background: Submucosal foreign bodies of the medial pyriform sinus represent a challenge given limited visualization and difficult retraction with endoscopic approaches, and risk of injury to the recurrent laryngeal nerve with open approaches. Transoral robotic surgery (TORS) offers improved visualization and multiple working arms to facilitate retraction. We present a novel case utilizing the Da Vinci SP system for removal of an embedded fishbone of the medial pyriform sinus. Results: An 84‐year‐old woman presented with five days of odynophagia and globus sensation after swallowing a fish bone. Non‐contrast computed tomography scan revealed a 3.0 cm submucosal object within the post‐cricoid soft tissue. On initial rigid endoscopy, the foreign body was completely submucosal and could not be identified. She ultimately underwent robotic‐assisted removal of the foreign body with the DaVinci SP system. Using the Feyh–Kastenbauer retractor with a laryngeal blade for exposure, the post‐cricoid and medial pyriform mucosa were elevated in a submucosal plane superficial to the posterior cricoarytenoid muscle allowing for identification and removal of the foreign body. She resumed oral intake on postoperative day four and advanced to a regular diet. In‐office laryngoscopy at two weeks demonstrated normal vocal fold mobility bilaterally. Conclusion: TORS with the DaVinci SP system allows for greater access, visualization, and dexterity within the pyriform sinus than traditional endoscopic approaches while avoiding the morbidity of open surgery, making it an ideal option for embedded foreign bodies and other submucosal pathologies.


  • Long‐Term Outcomes After Elective Contralateral Neck Dissection for HPV‐Related Oropharyngeal Cancer

    by Ray Y. Wang, Molly E. Heft Neal, Wade L. Thorstad, Hiram A. Gay, Anthony J. Apicelli, Michael J. Moravan, Douglas R. Adkins, Peter J. Oppelt, Patrik Pipkorn, Jason T. Rich, et al.

    Objective: Patients with human papillomavirus (HPV)‐related oropharyngeal squamous cell carcinoma (OPSCC), particularly of the base of tongue, have a high rate of occult nodal disease in the contralateral neck. The risk of failure in the contralateral neck is reduced with elective treatment. The optimal treatment strategy to minimize treatment‐related toxicity while preserving regional control in the contralateral neck has not been elucidated.Study Design: Cross‐sectional study of patients who underwent elective contralateral neck dissection as part of primary surgical treatment for HPV‐related OPSCC between January 2002 and December 2018.Setting: Tertiary care center.Methods: Patients who underwent elective contralateral neck dissection as part of primary surgical treatment for HPV‐related OPSCC between January 2002 and December 2018 were selected for inclusion. Long‐term patient‐reported functional outcomes were assessed via telephone at the time of data collection.Results: In total, 64 patients met the criteria for inclusion with a median follow‐up of 58.5 months. In total, 56 patients (88%) had a primary cancer within the base of tongue or glossotonsillar sulcus. In total, 12 patients (19%) were found to have occult nodal metastasis in the contralateral neck, of whom 9 received adjuvant contralateral neck radiation. None of the patients who had node‐negative contralateral neck dissections went on to receive radiation in the contralateral neck. Two patients (3%) recurred locally, two patients (3%) developed ipsilateral regional recurrence, and four patients (6%) developed distant metastasis. There were no regional recurrences within the contralateral neck. Five‐year progression‐free survival was 82.0%, whereas 5‐year locoregional control was 93.0%. The mean Neck‐Dissection Impairment Index was 94.4 with a median interval time of 92 months after surgery.Conclusion: Elective contralateral neck dissection in patients with HPV‐related OPSCC provides excellent regional control with minimal long‐term functional impairment, and most patients can be spared contralateral neck radiation without compromising oncologic outcomes. This may decrease long‐term toxicity related to bilateral neck irradiation.


  • Safety of An Enhanced Recovery After Surgery Protocol After Head and Neck Free Tissue Transfer

    by Ari D. Schuman, Mohini Bindal, Grace Amadio, Anne M. Turney, David J. Hernandez, Vlad C. Sandulache, N. Eddie Liou, Ray Wang, Andrew T. Huang

    Objectives: Implementing enhanced recovery after surgery (ERAS) protocols and decreasing length of stay (LOS) have become a priority for major surgeries, including microvascular free tissue transfer (MVFTT) reconstruction of the head and neck. We describe an ERAS protocol with the goal to further reduce length of stay beyond national medians.Methods: Retrospective chart review between August 2016 and February 2023, including all patients who underwent MVFTT after oral cavity, skull base, salivary gland, and cutaneous ablative surgery. An ERAS protocol was implemented in March 2020.Results: A total of 383 patients were included. Approximately 59.8% underwent oral cavity MVFTT, 34.5% cutaneous and lateral skull base, and 5.8% maxillary and anterior skull base. A total of 209 (54.7%) patients had surgery prior to implementation of the ERAS protocol and 174 (45.3%) after. Median LOS decreased from 9 days (interquartile interval [IQR] 8–11) to 6 (IQR 5–7.5, p < 0.0001) following oral cavity MVFTT. For cutaneous and lateral skull base reconstruction, median LOS decreased from 6 days (IQR 5–8) to 3 (IQR 3–7, p < 0.0001). For anterior skull base and sinonasal MVFTT, median LOS decreased from 8 (IQR 7–9) to 5 days (IQR 4.5–7, p = 0.0005). Rate of discharge to skilled nursing or subacute rehabilitation facilities decreased (24% before ERAS, 9.2% after, p < 0.0001). Thirty‐day readmission rate was similar before and after implementation (10.5% vs. 10.3, p = 0.954). Discharge to facility was associated with readmission (OR 2.34, 95% CI 1.12–4.89, p = 0.024).Conclusion and Relevance: Implementation of the ERAS protocol was associated with decreased LOS. There was no increase in rate of readmission.Level of Evidence: NA Laryngoscope, 134:4527–4534, 2024


  • Open Access

    Review of: "[Commentary] Implications of HPV infectivity in early diagnosis and treatment of advanced/recurrent malignancies"

    by Ray Wang

    The authors present a review of the significance of HPV in the pathogenesis and treatment of various malignancies. They briefly address several aspects of this topic, including epidemiology, preventative measures, and differences in treatment respons...

  • Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression

    by Ray Wang, Peter Horwich, Vlad C. Sandulache, David J. Hernandez, Joshua Hornig, Evan M. Graboyes, Nelson E. Liou, Judith Skoner, Angela D. Haskins, Viran Ranasinghe, et al.

    Background Patients on chronic pharmacologic immunosuppressive therapy are at increased risk of wound infection and complications after surgery. There is a paucity of data examining perioperative complications after microvascular free tissue transfer (MVFTT) reconstruction of the head and neck in this patient population. Methods Retrospective cohort study performed at two tertiary referral centers between August 2016 and May 2020. Results Nine hundred and seventy-nine patients underwent MVFTT during the study period; of these 47 (5%) patients were taking chronic immunosuppressive medications. The most common indications for immunosuppression were solid organ transplant and autoimmune disease. Fourteen (30%) patients had surgical complications within 30 days of surgery: 8 (17%) wound dehiscences, 6 (12%) hematomas, and 2 (4%) surgical site infections. There was one total and one partial flap failure with a 30-day reoperation rate of 4%. Conclusions MVFTT of the head and neck appears to be safe in patients on chronic pharmacologic immunosuppression.


  • Pediatric Tracheal Lobular Capillary Hemangioma: A Case Report and Review of the Literature

    by Ray Y. Wang, Norma M. Quintanilla, Bruno P. Chumpitazi, Sarah Gitomer, Eric H. Chiou, Julina Ongkasuwan

    Chronic cough is a common complaint in the pediatric population and can have many different etiologies. We present a rare case of a tracheal lobular capillary hemangioma (LCH), also known as pyogenic granuloma, causing chronic cough in a child. In this case, the tracheal LCH was managed successfully with laser ablation. A review of the literature reveals only 2 other reported pediatric cases of tracheal LCH. Laryngoscope, 131:1729–1731, 2021